Detalles de la búsqueda
1.
Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer.
Cancer Causes Control
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578428
2.
Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
Int J Cancer
; 150(5): 773-781, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648676
3.
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis.
Pigment Cell Melanoma Res
; 37(3): 352-362, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38158376
4.
High proliferation is associated with inferior outcome in male breast cancer patients.
Mod Pathol
; 26(1): 87-94, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22918167
5.
Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study.
Cancer Med
; 12(12): 13217-13224, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37132258
6.
Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors.
Oncoimmunology
; 10(1): 1886725, 2021 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33643697
7.
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer.
Acta Oncol
; 49(6): 816-20, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20307242
8.
Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.
Ups J Med Sci
; 125(4): 325-329, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33043759
Resultados
1 -
8
de 8
1
Próxima >
>>